FDA CONSUMER HEALTH INFORMATION - FDA Approves New Prostate Cancer Therapy

SILVER SPRING, Md., May 5 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) has approved a new treatment for certain men with advanced prostate cancer.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO)

Called Provenge (sipuleucel-T), the treatment stimulates a patient's own immune system to respond against the cancer.

Learn more about FDA's approval of Provenge at http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm210620

Sign up for e-mail notices of new FDA Consumer Updates at https://service.govdelivery.com/service/subscribe.html?code=USFDA_9

View the FDA Consumer Update RSS feed at http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/Consumers/rss.xml

FDA Consumer Updates may be posted and published elsewhere without permission. Please credit "FDA Consumer Health Information (www.fda.gov/consumer)" as the source. FDA values feedback on its consumer health information. Send questions, comments, or story ideas to: [email protected].

SOURCE U.S. Food and Drug Administration